APOPTOSIS TECHNOLOGY INC has a total of 26 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KINCH MICHAEL S, JALKANEN MARKKU TAPANI and TSS BIOTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Goldmakher Viktor S | 9 |
#2 | Skaletskaya Anna | 9 |
#3 | Bartle Laura | 6 |
#4 | Lutz Robert J | 5 |
#5 | Chittenden Thomas D | 5 |
#6 | Zhou Xiao-Mai | 4 |
#7 | O'Connor Rosemary | 3 |
#8 | Lehar Sophie M | 3 |
#9 | Bartle Laura M | 3 |
#10 | Baserga Renato L | 3 |
Publication | Filing date | Title |
---|---|---|
AU5125300A | Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis | |
EP1080233A1 | Compounds, screening methods, and uses involving anti-apoptotic genes and gene products | |
US6221615B1 | Peptides and compositions which modulate apoptosis | |
US6218511B1 | Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use | |
US5958872A | Active survival domains of IGF-IR and methods of use | |
US5843659A | Apoptosis gene EI24, compositions, and methods of use | |
US5656725A | Peptides and compositions which modulate apoptosis |